|
Back to Home » December 2021 News » Recursion Announces Transformational Collaboration with Roche and Genentech in Neuroscience and Oncology, Advancing Novel Medicines to Patients Using Machine Learning and High Content Screening Methods at Scale to Map Complex Biology |
Recursion Announces Transformational Collaboration with Roche and Genentech in Neuroscience and Oncology, Advancing Novel Medicines to Patients Using Machine Learning and High Content Screening Methods at Scale to Map Complex Biology |
December 07, 2021
SALT LAKE CITY, Dec. 7, 2021 /PRNewswire/ -- Recursion (NASDAQ: RXRX), a clinical-stage biotechnology company decoding biology to radically improve lives by industrializing drug discovery, development and beyond through disruptive innovation, today announced a transformational...
Source URL: https://www.prnewswire.com:443/news-releases/recursion-announces-transformational-collaboration-with-roche-and-genentech-in-neuroscience-and-oncology-advancing-novel-medicines-to-patients-using-machine-learning-and-high-content-screening-methods-at-scale-
|
|
|
|
